Abstract
Target therapy for driver gene-positive cases is one of the standard treatments in advanced or recurrent non-small cell lung cancer (NSCLC). However, there is a need for a simple method to find rare driver genes due to their rarity. We developed and evaluated the algorithm to detect rare driver gene in NSCLC comprehensively using pathological images and AI.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have